1190971-08-4

Upstream product

• 1191265-66-3 ((S)-1,2,3,4-tetrahydro-quinolin-2-yl)methanol hydrochloride 
• 55661-08-0 4-methoxy-2,6-dimethylbenzenesulfonyl chloride 
• 1190971-07-3 (S)-tert-butyl 2-(hydroxymethyl)-3,4-dihydroquinoline-1(2H)-carboxylate 
• 874-63-5 3,5-dimethylmethoxybenzene 

Downstream Products

• 1190971-09-5 tert-butyl 2-(((S)-1-(4-methoxy-2,6-dimethyl-phenylsulfonyl)-1,2,3,4-tetrahydro-quinolin-2-yl)methoxy)acetate 
• 1190971-00-6 (S)-2-((1-(4-methoxy-2,6-dimethylphenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)methoxy)acetic acid 
• 1190970-97-8 2-[[(2S)-1-[(4-methoxy-2,6-dimethyl-phenyl)sulfonyl]-1,2,3,4-tetrahydro-quinolin-2-yl]-methoxy]-1-(3-pyridin-4-yl-4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridin-5-yl)-ethanone 

Relevant academic research and scientific papers

SUBSTITUTED SULFONAMIDE DERIVATIVES

The invention relates to substituted sulfonamide derivatives, processes for the preparation thereof, medicaments containing these compounds and the use of substituted sulfonamide derivatives for the preparation of medicaments.

SUBSTITUTED SULFONAMIDE COMPOUNDS

Substituted sulfonamide compounds corresponding to formula I processes for the preparation thereof, pharmaceutical compositions containing these compounds, and the use of such substituted sulfonamide compounds in pharmaceutical compositions for the treatment and/or inhibition of pain and other conditions at least partly mediated by the bradykinin 1 receptor